EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repurposing iron chelators for accurate positron emission tomography imaging tracking of radiometal‐labeled cell transplants

Qian Xu, Xinyu Wang, Ziqian Mu, Yixiang Zhou, Xiang Ding, Xin Ji, Junjie Yan, Donghui Pan, Chongyang Chen, Yuping Xu, Lizhen Wang, Jing Wang und 2 weitere

MedComm · 2024-02 · 5 (2)

DOI: 10.1002/mco2.473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm, online erschienen am 30.01.2024. Verfasst von Qian Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiopharmaceuticals School of Pharmacy Nanjing Medical University Nanjing China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of radiolabeled cells for positron emission tomography (PET) imaging tracking has been a promising approach for monitoring cell‐based therapies. However, the presence of free radionuclides released from dead cells during tracking can interfere with the signal from living cells, leading to inaccurate results. In this study, the effectiveness of the iron chelators deferoxamine (DFO) and deferiprone in removing free radionuclides 89 Zr and 68 Ga, respectively, was demonstrated in vivo utilizing PET imaging. The use of DFO during PET imaging tracking of 89 Zr‐labeled mesenchymal stem cells (MSCs) significantly reduced uptake in bone while preserving uptake in major organs, resulting in more accurate and reliable tracking. Furthermore, the clearance of free 89 Zr in vivo resulted in a significant reduction in radiation dose from 89 Zr‐labeled MSCs. Additionally, the avoidance of free radionuclide accumulation in bone allowed for more precise observation of the homing process and persistence during bone marrow transplantation. The efficacy and safety of this solution suggest this finding has potential for widespread use in imaging tracking studies involving various cells. Moreover, since this method employed iron chelator drugs in clinical use, which makes it is a good prospect for clinical translation.

Schlagwörter

Stichwörter der Autor:innen

PET imagingcell therapycell trackingiron chelatorradiolabel

Autor:innen und Institutionen

  • Department of Radiopharmaceuticals School of Pharmacy Nanjing Medical University Nanjing China.
  • NHC Key Laboratory of Nuclear Medicine Jiangsu Key Laboratory of Molecular Nuclear Medicine Jiangsu Institute of Nuclear Medicine Wuxi China.
  • Jiangsu Renocell Biotech Co., Ltd. Nanjing China.
  • Key Laboratory of Drug Metabolism and Pharmacokinetics State Key Laboratory of Natural Medicines China Pharmaceutical University Nanjing China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xu, Q., Wang, X., Mu, Z., Zhou, Y., Ding, X., Ji, X., Yan, J., Pan, D., Chen, C., Xu, Y., Wang, L., Wang, J., Wang, G., & Yang, M. (2024). Repurposing iron chelators for accurate positron emission tomography imaging tracking of radiometal‐labeled cell transplants. MedComm, 5(2). https://doi.org/10.1002/mco2.473

Vancouver

Xu Q, Wang X, Mu Z, Zhou Y, Ding X, Ji X, et al. Repurposing iron chelators for accurate positron emission tomography imaging tracking of radiometal‐labeled cell transplants. MedComm. 2024;5(2). doi:10.1002/mco2.473

BibTeX
@article{Xu2024,
  author = {Xu, Qian and Wang, Xinyu and Mu, Ziqian and Zhou, Yixiang and Ding, Xiang and Ji, Xin and Yan, Junjie and Pan, Donghui and Chen, Chongyang and Xu, Yuping and Wang, Lizhen and Wang, Jing and Wang, Guangji and Yang, Min},
  title = {Repurposing iron chelators for accurate positron emission tomography imaging tracking of radiometal‐labeled cell transplants},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {2},
  doi = {10.1002/mco2.473}
}
Kostenlos starten →